Studying harms of interventions with an equity lens in randomized trials

被引:1
|
作者
Li, Tianjing [1 ,2 ]
Mayo-Wilson, Evan [3 ]
Shaughnessy, Daniel [1 ,2 ]
Qureshi, Riaz [1 ,2 ]
机构
[1] Univ Colorado, Dept Ophthalmol, Anschutz Med Campus, Aurora 80045, CO USA
[2] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO 80045 USA
[3] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA
关键词
Equity; Health equity; Disparity; Harms; Randomized trials; VACCINE HESITANCY; HEALTH EQUITY; SAFETY;
D O I
10.1186/s13063-024-08239-x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Equity and health equity are fundamental pillars in fostering a just and inclusive society. While equity underscores fairness in resource allocation and opportunity, health equity aims to eradicate avoidable health disparities among social groups. The concept of harms in interventions-undesirable consequences associated with the use of interventions-often varies across populations due to biological and social factors, necessitating a nuanced understanding. An equity lens reveals disparities in harm distribution, urging researchers and policymakers to address these differences in their decision-making processes. Furthermore, interventions, even well-intentioned ones, can inadvertently exacerbate disparities, emphasizing the need for comprehensive harm assessment. Integrating equity considerations in research practices and trial methodologies, through study design or through practices such as inclusive participant recruitment, is pivotal in advancing health equity. By prioritizing interventions that address disparities and ensuring inclusivity in research, we can foster a more equitable healthcare system.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Harms Reporting in Randomized Controlled Trials of Interventions Aimed at Modifying Microbiota RESPONSE
    Bafeta, Aida
    Koh, Mitsuki
    Riveros, Carolina
    Ravaud, Philippe
    ANNALS OF INTERNAL MEDICINE, 2019, 170 (02) : 143 - 144
  • [2] Harms Reporting in Randomized Controlled Trials of Interventions Aimed at Modifying Microbiota A Systematic Review
    Bafeta, Aida
    Koh, Mitsuki
    Riveros, Carolina
    Ravaud, Philippe
    ANNALS OF INTERNAL MEDICINE, 2018, 169 (04) : 240 - +
  • [3] CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials
    Junqueira, Daniela R.
    Zorzela, Liliane
    Golder, Susan
    Loke, Yoon
    Gagnier, Joel J.
    Julious, Steven A.
    Li, Tianjing
    Mayo-Wilson, Evan
    Pham, Ba
    Phillips, Rachel
    Santaguida, Pasqualina
    Scherer, Roberta W.
    Gotzsche, Peter C.
    Moher, David
    Ioannidis, John P. A.
    Vohra, Sunita
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2023, 158 : 149 - 165
  • [4] Harms, benefits, and the nature of interventions in pragmatic clinical trials
    Ali, Joseph
    Andrews, Joseph E.
    Somkin, Carol P.
    Rabinovich, C. Egla
    CLINICAL TRIALS, 2015, 12 (05) : 467 - 475
  • [5] Strengthening the reporting of harms of all interventions in clinical trials
    Shaheed, Christina Abdel
    Maher, Christopher G.
    Furmage, Ann-Mason
    Hoffmann, Tammy
    McLachlan, Andrew J.
    MEDICAL JOURNAL OF AUSTRALIA, 2022, 217 (10) : 502 - 504
  • [6] Reporting of harms in randomized controlled trials of psychological interventions for mental and behavioral disorders: A review of current practice
    Jonsson, Ulf
    Alaie, Iman
    Parling, Thomas
    Arnberg, Filip K.
    CONTEMPORARY CLINICAL TRIALS, 2014, 38 (01) : 1 - 8
  • [7] A framework for identifying and mitigating the equity harms of COVID-19 policy interventions
    Glover, Rebecca E.
    van Schalkwyk, May C. I.
    Akl, Elie A.
    Kristjannson, Elizabeth
    Lotfi, Tamara
    Petkovic, Jennifer
    Petticrew, Mark P.
    Pottie, Kevin
    Tugwell, Peter
    Welch, Vivian
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2020, 128 : 35 - 48
  • [8] Protocol for the development of a CONSORT-equity guideline to improve reporting of health equity in randomized trials
    Welch, Vivian
    Jull, J.
    Petkovic, J.
    Armstrong, R.
    Boyer, Y.
    Cuervo, L. G.
    Edwards, S. J. L.
    Lydiatt, A.
    Gough, D.
    Grimshaw, J.
    Kristjansson, E.
    Mbuagbaw, L.
    McGowan, J.
    Moher, D.
    Pantoja, T.
    Petticrew, M.
    Pottie, K.
    Rader, T.
    Shea, B.
    Taljaard, M.
    Waters, E.
    Weijer, C.
    Wells, G. A.
    White, H.
    Whitehead, M.
    Tugwell, P.
    IMPLEMENTATION SCIENCE, 2015, 10 : 1
  • [9] Protocol for the development of a CONSORT-equity guideline to improve reporting of health equity in randomized trials
    Vivian Welch
    J. Jull
    J. Petkovic
    R. Armstrong
    Y. Boyer
    LG Cuervo
    SJL Edwards
    A. Lydiatt
    D. Gough
    J. Grimshaw
    E. Kristjansson
    L. Mbuagbaw
    J. McGowan
    D. Moher
    T. Pantoja
    M. Petticrew
    K. Pottie
    T. Rader
    B. Shea
    M. Taljaard
    E. Waters
    C. Weijer
    GA Wells
    H. White
    M. Whitehead
    P. Tugwell
    Implementation Science, 10
  • [10] Preparing for pragmatic trials in dementia care: Health equity considerations for nonpharmacological interventions
    Aranda, Maria P.
    Baier, Rosa
    Hinton, Ladson
    Peak, Katherine D.
    Jackson, Jonathan D.
    Dilworth-Anderson, Peggye
    Gitlin, Laura N.
    Jutkowitz, Eric
    Quinones, Ana R.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 (12) : 3874 - 3885